• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 212
  • 161
  • 57
  • 27
  • 27
  • 27
  • 27
  • 27
  • 27
  • 16
  • 2
  • 1
  • 1
  • Tagged with
  • 431
  • 209
  • 72
  • 63
  • 56
  • 44
  • 41
  • 41
  • 37
  • 35
  • 35
  • 33
  • 33
  • 30
  • 29
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
171

A atividade da enzima Glicogênio Sintase Quinase 3 Beta (GSK-3B) em pacientes idosos com depressão maior: associação com parâmetros clínicos, psicopatológicos e cognitivos / Glycogen Synthase Kinase 3 Beta (GSK-3B) activity in elderly patients with major depressive disorder: association with clinical, psychopathological and cognitive aspects

Breno Satler de Oliveira Diniz 23 May 2011 (has links)
Apesar da elevada prevalência dos transtornos depressivos em idosos, os mecanismos fisiopatológicos subjacentes a estes quadros são pouco conhecidos. Atualmente, o principal foco dos estudos sobre a fisiopatologia da depressão geriátrica são as alterações cerebrovasculares associadas a estes quadros. Outros mecanismos fisiopatológicos têm sido estudados, como as alterações em cascatas neurotróficas e inflamatórias. A enzima glicogênio sintase quinase 3 beta (GSK-3B) tem sido implicada na patogênese de diversos transtornos mentais, em especial os transtornos afetivos (i.e. depressão maior e o transtorno afetivo bipolar) e doenças neurodegenerativas (i.e. doença de Alzheimer). Entretanto, não há estudos que avaliam o papel desta enzima nos pacientes idosos com depressão maior. Desta maneira, o objetivo principal deste trabalho é avaliar a atividade da GSK-3B em pacientes idosos com depressão maior. A hipótese deste estudo é que a atividade enzimática está aumentada nos pacientes idosos deprimidos em relação a idosos saudáveis. Para este estudo, recrutamos 40 idosos com depressão maior (de acordo com os critérios diagnósticos do DSM-IV) e que não estavam em uso de antidepressivos. O grupo comparativo foi constituído por 13 idosos saudáveis, sem evidências de transtornos cognitivos ou do humor. A gravidade da sintomatologia depressiva foi avaliada pela escala de depressão de Hamilton de 21 itens (HAM-D); o desempenho cognitivo dos pacientes e controles foi avaliado pelo teste cognitivo de Cambridge (CAMCOG) e pelo mini-exame do estado mental (MEEM). A expressão da GSK-3B foi determinada em plaquetas através de ensaio imunoenzimático (EIA), sendo estabelecido os níveis totais da GSK-3B (T-GSK-3B) e de sua forma fosforilada (P-GSK-3B), inativa. A atividade enzimática foi inferida indiretamente pela razão P-GSK- 3B / T-GSK-3B. Nos pacientes idosos com depressão maior, observou-se uma redução significante dos níveis P-GSK-3B (p=0,03) e da razão da GSK- 3B (p=0,03). Os pacientes com sintomatologia depressiva mais grave (HAMD > 21) e déficits cognitivos mais intensos (CAMCOG < 86) apresentaram maior atividade enzimática (p=0,03 e teste, p=0,01, respectivamente). Os resultados deste trabalho sugerem que a atividade da GSK-3B está significantemente aumentada em pacientes idosos com depressão maior e que está alteração é mais pronunciada nos pacientes com sintomatologia depressiva e déficits cognitivos mais graves. Neste contexto, a atividade da GSK-3B pode ser considerada um marcador de estado em pacientes idosos com episódios depressivos mais graves e ser um importante alvo para o desenvolvimento de estratégias terapêuticas para estes quadros / Despite the high prevalence of depressive disorders in the elderly, its main physiopathological mechanisms are largely unknown. In the recent years, most of the research efforts focused on the association between cerebrovascular changes and geriatric depression. Nonetheless, other mechanisms have been studied, such as changes in neurotrophic and inflammatory cascades. The enzyme glycogen synthase kinase 3 beta (GSK- 3B) has been implicated in many mental disorders, in particular affective disorders (i.e. major depression and bipolar disorder) and neurodegenerative disorders (i.e. Alzheimers disease). However, there is no study so far that addressed the role of this enzyme in elderly patients with major depression. Therefore, the main objective of this study was to evaluate if GSK-3B activity is changed in elderly patients with major. The working hypothesis is that enzyme activity is significantly increased in elderly patients with major depression as compared to elderly controls. We recruited 40 elderly patients with current major depressive episode (according to the DSM-IV criteria) that was not under antidepressant treatment. The comparison group included 13 healthy elderly subjects with no evidence of cognitive impairment or major psychiatric disorder. The severity of depressive symptoms was assessed by the Hamilton Depression Scale 21 items; cognitive performance was assessed by the Cambridge Cognitive test (CAMCOG) and the Mini-mental State Examination (MMSE). The levels of total and phosphorylated GSK-3B (T-GSK-3B and P-GSK-3B, respectively) levels were determined in platelets by immunoenzymatic assay (EIA). Enzyme activity was indirectly inferred by the ratio P-GSK-3B / T-GSK-3B. Elderly patients with major depression had a significant reduction in the P-GSK-3B levels (p = 0.03) and GSK-3B ratio (p= 0.03). The patients with severe depressive episode (HAM-D scores above 21 points) and cognitive impairment (CAMCOG scores below 86 points) presented the more significant reduction of GSK-3B ratio (p = 0.03 and p = 0.01, respectively). These data altogether suggest that GSK-3B activity is significantly increased in elderly patients with major depression, in particular in those with more severe depressive episode and worse cognitive performance. In this context, the increased enzyme activity may be regarded as a state marker of severe depressive episodes and may an important target to the development of therapeutic strategies to this disorder
172

Caracterização das fases imediata e tardia da resposta inflamatória de tecido pulmonar periférico de cobaias sensibilizadas / Comparison of early and late responses to antigen of sensitized guinea pigs parenchymal lung strips

Tatiana Lanças 21 September 2006 (has links)
O parênquima pulmonar periférico tem sido estudado como um componente da resposta inflamatória na asma. Durante uma constrição induzida, a resistência do tecido aumenta em diferentes modelos de asma. Aproximadamente 60% dos pacientes asmáticos possuem respostas imediata e tardia. A resposta tardia é caracterizada por obstrução mais grave de vias aéreas. No presente estudo, foi avaliada a mecânica de fatias de parênquima pulmonar em cobaias sensibilizadas com ovoalbumina (OVA), tentando reproduzir ambas as repostas imediata e tardia. A mecânica oscilatória de fatias pulmonares foi realizada em um grupo controle (C), em um grupo de resposta imediata (IM) e em dois grupos de resposta tardia: 17 (T1) e 72 (T2) horas após o último desafio com ovoalbumina. Medidas de resistência (R) e elastância (E) foram obtidas antes e depois do desafio com OVA nos grupos C e IM e antes e depois do desafio com Acetilcolina (ACh) em todos os grupos. Com o uso de morfometria, foram avaliadas as densidades de eosinófilos e de células musculares lisas, assim como o conteúdo de colágeno e elastina nas fatias pulmonares. Os valores de R e E basais e pós-agonista estão aumentados nos grupos IM, T1 e T2 quando comparados com o grupo C (p = 0.001). A análise morfométrica mostrou um aumento na densidade de eosinófilos nas fatias de tecido periférico dos grupos IM e T2 quando comparados com o grupo C (p < 0.05). Houve uma correlação positiva significante entre a densidade de eosinófilos nas fatias de parênquima dos grupos C, T1 e T2 e os valores de R e E pós-ACh (r = 0,71, p = 0.001 e r = 0,74, p < 0.001, respectivamente). Os resultados mostram que o parênquima pulmonar está envolvido na resposta tardia deste modelo de inflamação alérgica crônica e que a resposta constritora nesta fase está relacionada à inflamação eosinofílica. / The peripheral lung parenchyma has been studied as a component of the asthmatic inflammatory response. During induced constriction, tissue resistance increases in different asthma models. Approximately 60% of the asthmatic patients show early and late responses. The late response is characterized by more severe airway obstruction. In the present study, we evaluated lung parenchymal strips mechanics in ovalbumin-sensitized guinea pigs, trying to reproduce both early and late inflammatory responses. Oscillatory mechanics of lung strips were performed in a control group (C), in an early response group (ER), and in two late response groups: 17 (L1) and 72 (L2) hours after the last ovalbumin challenge. Measurements of resistance and elastance were obtained before and after ovalbumin challenge in C and ER groups and before and after Acetylcholine challenge in all groups. Using morphometry, we assessed the density of eosinophils and smooth muscle cells, as well as collagen and elastin content in lung strips. The baseline and post-agonist values of resistance and elastance were increased in ER, L1 and L2 groups compared with C (p = 0.001). The morphometric analysis showed an increase in alveolar eosinophil density in ER and L2 groups compared with C group (p < 0.05). There was a significant correlation between eosinophil density in parenchymal strips of C, L1 and L2 groups and values of resistance and elastance post-Acetylcholine (r = 0.71, p = 0.001 and r=0.74, p < 0.001, respectively). The results show that the lung parenchyma is involved in the late response of this guinea pig model of chronic allergic inflammation and the constriction response in this phase is related to the eosinophilic inflammation.
173

Mise en place d’un modèle cellulaire permettant l’exploration fonctionnelle du canal ionique NALCN : caractérisation du courant de fuite induit par le canal humain NALCN et de différents mutants rencontrés dans un contexte pathologique / Setting a cellular model to functionnally explore the ion channel NALCN activity : characterization of human NALCN leak current and differents mutants in a pathological context

Bouasse, Malik 20 September 2017 (has links)
L'activité électrique des neurones dépend de la l’expression et de l'activité des canaux ioniques, dont le canal de fuite de sodique récemment décrit, appelé NALCN. Dans les neurones, NALCN est un canal activé par un récepteur couplé aux protéines G qui conduit un courant de fuite de sodium résistant à la TTX et résistant à Cs + et contribue à la mise en place du potentiel de la membrane du repos. Chez l'homme, des mutations récessives et dominantes de NALCN ont récemment été décrites dans des troubles neurologiques complexes tels que la Dystrophie Neuroaxonale Infantile (syndrome INAD) et l'Arthrogryposis Distal de Type 2A (syndrome CLIFHADD). Ces troubles partagent des symptômes communs tels que l'ataxie, les crises épileptiques, l'hypotonie, le retard cognitif et le retard de développement. Les conséquences fonctionnelles de ces mutations NALCN ne sont toutefois pas connues principalement en raison de l'absence d'un modèle cellulaire reproductible pour réaliser une analyse électrophysiologique du courant NALCN. Dans la présente étude, nous décrivons les propriétés des canaux NALCN recombinants dans la lignée cellulaire neuronale, NG108-15. Ces cellules, qui expriment les sous-unités auxiliaires UNC79 et UNC80 de NALCN, ont été transfectées avec des constructions encodant NALCN (type sauvage ou mutants) et sa sous-unité NLF-1. Après la transfection du NALCN de type sauvage, les enregistrements par la technique de patch-clamp ont révélé la présence d'un courant de fuite entrant dans des cellules différenciées. A noter que la transfection des mutants CLIFHADD a entraîné l'expression d'un courant de fuite de sodium significativement plus élevé, comparé aux cellules exprimant des canaux NALCN de type sauvage. Au contraire, aucun courant de ce genre n'a été observé dans les cellules exprimant le mutant INAD. Ces résultats confirment fortement l'hypothèse selon laquelle les mutations dominantes CLIFHADD est un gain de fonction, alors que l'INAD est une mutation de perte de fonction. En conclusion, nos données démontrent que la lignée cellulaire NG108-15 est un modèle cellulaire fiable pour étudier l'activité électrophysiologique des canaux NALCN de type sauvage et mutant. / Electrical activity of neurons is critically dependent on the presence and activity of ion channels, including the recently described “sodium-leak channel” named NALCN. In neurons, NALCN is a G protein-coupled receptor-activated channel that conducts a TTX-resistant and Cs+-resistant sodium-leak current and contributes to setting-up the resting’s membrane potential. In humans, both recessive and dominant mutations of NALCN were recently described in complex neurological disorders such as Infantile Neuroaxonal Dystrophy (INAD) and Type 2A Distal Arthrogryposis (CLIFHADD). These disorders share common symptoms such as ataxia, epileptic seizures, hypotonia, cognitive delay and developmental retardation. The functional consequences of these NALCN mutations are however not known mainly because of the lack of a reliable cellular model to achieve electrophysiological analysis of the NALCN current. In the present study, we describe the properties of recombinant NALCN channels in the neuronal cell line, NG108-15. These cells, which express the NALCN’s ancillary subunits Unc79 and Unc80, were transfected with constructs encoding NALCN (wild-type or mutants) and its NLF-1 subunit. Following transfection of the wild-type NALCN, patch-clamp recordings revealed the presence of an inward background current in differentiated cells. Importantly, transfection of the CLIFHADD mutants resulted in the expression of a significantly larger sodium-leak current, compared to cells expressing wild-type NALCN channels. On the contrary, no such current was observed in cells expressing the INAD mutant. These results strongly support the hypothesis that CLIFHADD are gain-of-function, while INAD are loss-of-function mutations. Altogether, our data demonstrate that the NG108-15 cell line is a reliable cellular model to study electrophysiological activity of wild-type and mutant NALCN channels
174

Examination of cardiovascular function in conscious hypertensive diabetic rats

Schenk, Johannes January 1991 (has links)
This investigation was concerned with measuring aspects of cardiac function in conscious control, diabetic, hypertensive control, and hypertensive diabetic rats. Preliminary studies were conducted to determine catheter suitability and acute responses to atropine and angiotensin II in conscious animals. The catheter-manometer was tested using a square wave impact and was shown to accurately reproduce a left ventricular pressure pulse. Intravenous atropine caused both heart rate and left ventricular +dP/dt to rise. Intravenously administered angiotensin II caused systolic blood pressure to increase dramatically. In this case heart rate fell and +dP/dt was elevated. Hypertension was induced with deoxycorticosterone acetate (DOCA) and saline drinking water. Rats were first made diabetic with streptozotocin (60 mg/kg; i.v.). One week following this, subcutaneous DOCA (25 mg/kg) was administered twice weekly and all animals received saline drinking water. Following 2 and 5 weeks of DOCA treatment rats were catheterized and resting cardiovascular function was measured. DOCA treatment caused increased systolic and diastolic blood pressures to occur in control and diabetic rats at 2 and 5 weeks. Bradycardia was also observed in DOCA-diabetic and DOCA-control rats at 2 and 5 weeks of treatment. Two and 5 week hypertensive diabetic and control rats exhibited elevated -dP/dt and +dP/dt. The rate of contraction was shown to be proportional to the magnitude of systolic blood pressure in all treatment groups. It is concluded that diabetic rats and control rats did not differ in their response to hypertension after 5 weeks of DOCA treatment. / Medicine, Faculty of / Anesthesiology, Pharmacology and Therapeutics, Department of / Graduate
175

The contribution of ephaptic interactions to recruitment and synchronization of neuronal discharge during evoked potentials in the hippocampal formation

Richardson, Thomas Lewellyn January 1988 (has links)
The mechanisms underlying the generation and spread of seizure activity have remained elusive despite a considerable research effort over the last two decades. Most of this work has concentrated on the characteristics of neuronal excitability and burst discharge at the single cell level. These studies have provided some understanding of the possible abnormalities of neurons within an epileptic focus, but little direct insight into the factors responsible for the striking synchronization of action potentials during interictal discharge or in the spread of synchronous activity across apparently normal brain tissue. Although synaptic activation probably plays a role in the generation of seizure activity, recent evidence indicates that seizure-like discharge can occur during chemical blockade of synaptic transmission (Jefferys and Haas 1982; Taylor and Dudek 1982). This rather surprising result emphasizes the importance of considering non-synaptic mechanisms for both the synchronization and spread of abnormal neuronal activity in the central nervous system. One important non-synaptic mechanism to consider is ephaptic interactions. This term refers to the direct electrical influence of extracellular field potentials on neuronal excitability. It is possible that ephaptic interactions, generated during seizure activity, simultaneously depolarize an entire population of neurons leading to both recruitment and synchronization of action potential discharge. This thesis investigates ephaptic interactions during evoked potentials in the hippocampal formation. The hippocampus is one of the most seizure-prone regions of the brain and its anatomical structure is ideal for the generation of field effects. Evoked potentials were used as "models" of synchronous neuronal discharge since they are more reproducible, easier to control, and better understood than seizure activity. This initial investigation of ephaptic interactions lays the foundation for further studies involving the complexities of epileptic activity. The first phase of this project examined the spatial characteristics of field potentials evoked in the hippocampus and the dentate gyrus. Current source density (CSD) analysis and voltage gradient determinations obtained from these fields were used to characterize the pattern of current flow within the neuropil and to predict the polarity and relative intensity of ephaptic influences on neuronal excitability. The detailed characteristics of extracellular voltage gradients varied between CAl and the dentate gyrus, and also between anti- and orthodromic responses. In general, voltage gradients during the positive components of a somatic population spike predicted ephaptic hyperpolarization of the neuronal population, whereas gradients observed during the negative component predicted depolarization. They were often an order of magnitude greater than the smallest gradient known to influence granule cell activity. An exception to this rule was the minimal gradient observed during the negative component of the dentate response. In the second phase of the study, extracellular voltage gradients were experimentally applied to the dentate gyrus to determine the sensitivity of granule cells to ephaptic interactions. The magnitude of the applied gradients were in the range observed during the evoked potentials studied in the first phase. These experiments demonstrated a remarkable sensitivity of granule cells to the applied fields. The fields could alter the population spike from near minimal to near maximal. Surprisingly, even antidromic potentials were influenced by the gradients. On the other hand, the EPSP phase of the population spike was not influenced. These findings established that extracellular currents can influence the excitability within a neuronal population without altering synaptic drive. The final phase of the project investigated the transmembrane potential (TMP) of pyramidal and granule cells during applied fields and evoked potentials. The TMP was calculated by subtracting the extracellular from the intracellular response. This potential ultimately determines the voltage dependent behavior of a neuron and gives a direct measure of any ephaptic interactions. In order to measure the intracellular influences of applied fields, the TMP was monitored while the impaled cell was exposed to extracellular voltage gradients spanning the same range as used in phase two of the project. The TMP shifted by as much as plus or minus 5 mV, depending on the amplitude and polarity of the gradient. This large shift in TMP accounts for the observed influence of the applied field potentials, and suggests that the voltage gradients associated with evoked potentials should also have a marked effect on the TMP. A depolarizing wave of the TMP occurred during the negative component of anti- and orthodromic CA1 responses. This depolarization was capable of initiating action potentials, and decreased the latency to discharge during orthodromic responses. During epileptiform discharge, a similar depolarizing wave was associated with each negative component of the burst. These depolarizations recruit and synchronize neuronal discharge by simultaneously increasing the excitability within an entire population of cells. These data support the hypothesis that ephaptic interactions in the hippocampal formation influence the pattern of cell discharge during evoked potentials. It is postulated that similar ephaptic interactions may contribute to recruitment and synchronization during seizure activity. / Medicine, Faculty of / Cellular and Physiological Sciences, Department of / Graduate
176

Analyse des altérations oncogéniques associées aux lymphomes NK/T de type nasal / Analysis of oncogenic alterations associated with extranodal NK/T-cell lymphomas of nasal type

Huang, Yen-Lin 16 December 2009 (has links)
Dans les pays occidentaux, les lymphomes T périphériques et NK représentent environ 10% des lymphomes non-Hodgkiniens. Le lymphome NK/T de type nasal est l'une des entités de présentation extra-ganglionnaire les plus fréquentes, en Asie, et en Amérique Centrale et du Sud. Il survient classiquement dans la sphère nasopharyngée avec une prédilection pour les adultes jeunes. Morphologiquement, la tumeur est souvent angiocentrique avec une invasion de la paroi des vaisseaux par les cellules tumorales d'aspect variable. Ces lymphomes ont le plus souvent une origine NK avec un phénotype CD3+ (cytoplasmique), CD5-, CD56+, CD4-/CD8-, expression des molécules cytotoxiques et absence de réarrangement des gènes des récepteurs T. Le virus d'Epstein-Barr est présent dans la quasi-totalité des cellules tumorales dans sa forme clonage épisomale, avec une latence de type II, suggérant son rôle dans l'oncogenèse. A côté des mutations fréquentes des gènes FAS et TP53 (p53) et des méthylations de TP73 et CDKN2A (p16), des délétions du bras long du chromosome 6q sont fréquemment observées. Très récemment, des méthylations et des mutations des gènes suppresseurs de tumeur PRDM1, ATG5, et AIM1 localisés en 6q21 ont été retrouvées dans les lignées de lymphome NK/T de type nasal. Nous avons réalisé une analyse combinée du profil d'expression génique et du profil génomique par hybridation comparative sur puces, d'échantillons tumoraux de lymphome NK/T de type nasal (n=9) et de lignées, comparés à celle de lymphocytes NK normaux et de lymphomes T périphériques, sans autre spécificité (PTCL, NOS). Nous avons identifié la signature moléculaire particulière du lymphome NK/T de type nasal caractérisée par un haut niveau des trascrits de marqueurs de cellules NK et de molécules cytotoxiques, notamment de granzyme H dans les lymphomes NK/T de type nasal comparé aux PTCL, NOS. Par immunohistochimie, nous avons validé l'expression "spécifique" de granzyme H par les cellules tumorales du lymphome NK/T de type nasal, qui pourrait constituer un nouveau marqueur de ces lymphomes. Comparé aux cellules NK normales, le lymphome NK/T de type nasal a une signature plus proche des cellules NK activées que des NK au repos et sur-expriment des gènes associés à la biologie vasculaire, des gènes induits par l'EBV, et PDGFRA. Nous avons confirmé l'expression protéique de PDGFRAa et de sa forme phosphorylée, et montré in vitro la sensibilité de la lignée tumorale MEC04 à l'imatinib mesytale. La dérégulation des voies de signalisation AKT, JAK-STAT et NF-kB, suggérée par les analyses bioinformatiques, a été corroborée par la mise en évidence d'une expression nucléaire des formes phosphorylées d'AKT, de STAT3 et de RelA dans les lymphomes NK/T de type nasal. De plus, plusieurs gènes dérégulés dans ces voies moléculaires sont localisés dans des régions altérées de manière récurrente par des gains ou des pertes (AKT3 (1q44), IL6R (1q21.3), CCL2 (17q12), TNFRSF21 (6p12.3)). En plus de l'activation constitutive de STAT3 confirmée par l'expression nucléaire de phospho-STAT3, l'inhibition de croissance et l'augmentation de la mort cellulaire des cellules de la lignée MEC04 résultant de l'inhibition de STAT3 conforte le rôle de STAT3 dan la lymphomagenèse du lymphome NK/T nasal. L'analyse intégrée a également mis en évidence la dérégulation du gène suppresseur de tumeur HACE1 en 6q21, confirmée par RT-PCR quantitative. Bien que les mécanismes exacts conduisant à l'activation de plusieurs voies moléculaires, de même qu'à la dérégultaion de HACE1 ne soient pas déterminés, nos résultats identifient plusieurs voies oncogéniques impliquées dans le lymphome NK/T de type nasal ainsi que de nouveaux biomarqueurs diagnostiques - comme granzyme H - et des cicles thérapeutiques d'intérêt. L'étude en cours du profil d'expression des microARNs pourrait apporter un éclairage sur les mécanismes impliqués dans certaines voies identifiées / In Western countries, mature natural killer (NK)- and T-cell lymphomas account for 15% to 20% of aggressive lymphomas and around 10 % of all non-Hodgkin lymphomas. This number is higher in Asia, with 25% in Japan and 39% in Taiwan. Among those T- and NK-cell lymphomas with primary extranodal presentation, extranodal NK/T-cell lymphoma of nasal type (nasal NKTCL) is one of the most common entities in Asian, Central and South American populations. It classically arises in the nasal region showing a predilection for young adults with male predominance. This tumor morphologically exhibits an angiocentric and angio destructive growth pattern, admixed with polymorphous non-neoplastic infiltrates. Most tumor cells have a cytoplasmic CD3+, CD5-, CD56+, CD4-/CD8- phenotype with expression of cytotoxic granule-associated proteins and without rearrangement of T-cell receptors genes. Killer immunoglobulin-like receptors have been reproted to be expressed in a subset of this lymphoma and its expression might be associated with prognosis. Epstein-Barr virus is present in virtually all neoplastic cells in its clonal episomal form with type II latency program, implying a role in oncogenesis. Although the results were variable between different studies, methylations of TP73 (p73) and CDKN2A (p16) and mutations of FAS and TP53 (p53) were frequently found in nasal NKTCL. Genomic alterations have also been reported in nasal NKTCL with frequent deletion in chromosome 6q. A very recent study also identified both methylations and mutations of three putative tumor suppressor genes PRDM, ATG5, and AIM1 mapping to del6q21 in nasal NKTCL cell times. We performed integrative gene expression profiling and array-based comparative genomic hybridization analyses of nasal NKTCL tumors as well as tumour-derived cell lines, compared to that of normal NK cells and peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS). We identified the distinctive molecular signature of nasal NKTCL with high transcript levels for NK-cell markers ans cytotoxic molecules, especially granzyme H in nasal NKTCL compared to PTCL, NOS. By immunohistochemistry, we validated expression of grnzyme H which appears a novel sensitive biomarker of nasal NKTCL. Compared to normal NK cells, nasal NKTCL tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, EBV-induced genes and PDGFRA. Notably, we confirmed the expression of PDGFRa and its phosphorylated form at the protein level, and in vitro the MEC04, nasal NKTCL-cell line, was sensitive to imatinib mesylate. Deregulation of the AKT, JAK-STAT and NF-kB pathways suggested by bioinformatical analysis, was corroborated by nuclear expression of phosphorylated AKT, STAT3 and RelA in nasal NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 (1q44), IL6R (1q21.3), CCL2 (17q12), TNFRSF21 (6p12.3)). In addition to constitutive activation of STAT3 as confirmed by the demonstration of phosphorylated STAT3 in the nuclei of neoplastic nasal NKTCL cells, growth inhibition and cell death of nasal NKTCL cells induced by STAT3 inhibition implied the role of STAT3 in the nasal NK/T-cell lymphomagenesis. Integrative analysis and qRT-PCR analysis also evidenced deregulation of another tumor suppressor HACE1 in the frequently deleed 6q21 region. Although the exact mechanism of activation of several pathways as well as that of HACE1 deregulation remains to be determined, our studies highlight emerging oncogenic pathways in nasal NKTCL and identify novel diagnostic and therapeutic targets. The ongoing investigation of microRNA expression profiling might shed light in a better understanding of the pathogenesis of nasal NKTCL and especially of the activation of oncogenic pathways. Connectivity map analysis may also help to depict other targeted therapies useful to improve the prognosis of this agressive lymphoma
177

The effect of electrolytic lesion and neural implants on glial fibrillary acidic protein expression in the rat spinal cord

Falconer, Robert J. January 1989 (has links)
This thesis assessed the suitability of unilateral, electrolytic lesions as a model of spinal cord damage and repair in the adult rat. This type of lesion resulted acutely in localized damage in the upper motor neuron at the L2-L3 level of the spinal cord. Minimal acute damage to ascending sensory pathways was indicated by preserved somatosensory evoked potentials elicited by stimulation of the tibial nerve. Immediately after lesion generation one of several substrates was injected into the lesion cavity. These substrates were saline buffer, liquid collagen solution, foetal spinal cord cells from 14 day old rat embryos, and a mixture of collagen and E 14 foetal spinal cord cells. The 4 groups were compared for functional recovery over 3 months using the inclined plane test and a Tarlov movement scale. After sacrifice, the tibialis anterior muscles were dissected and weighed to assess atrophy due to lower motor neuron injury. After removing and embedding the spinal cords in paraffin, transverse and longitudinal sections were taken for cytoarchitectural investigation. Cresyl violet was used to indicate Nissl substance, Luxol fast blue stained for myelin and anti - glial fibrillary acidic protein (GFAP) antibody revealed the expression of GFAP in the cord sections. Chronic electrolytic lesions were characterized by the highly variable degree of cavitation, demyelination and macrophage infiltration that was present. There was no significant performance deficit on the inclined plane test in any of the lesioned groups when compared to unoperated animals. The tibialis muscles from all groups were of normal weight, indicating that the lower motor neurons were not significantly damaged by the lesions used. There was, however, a marked decrease in the number of GFAP reactive astrocytes in the lesioned animals when compared to unlesioned controls (P < 0.01, Wilcoxon test). Moreover, this reduction of GFAP - like immunoreactivity was not prevented by implants of foetal neurons, collagen or foetal neurons suspended in collagen. Possible explanations for the reduced GFAP - like immunoreactivity seen in all electrolytically lesioned cords are discussed. / Medicine, Faculty of / Cellular and Physiological Sciences, Department of / Graduate
178

"Modulação do quimioreflexo por hipóxia e hipercapnia durante exercício submáximo na insuficiência cardíaca" / Chemoreflex modulation by hypoxia and hypercapnia through submaximal exercise in heart failure patients

Lidia Ana Zytynski Moura 22 August 2005 (has links)
A dispnéia na insuficiência cardíaca(IC) é complexa, com possível envolvimento de quimioreceptores periféricos(QP) e centrais(QC). Avaliamos a resposta de QP e QC no exercício submáximo em 15 pcts com IC e 7 ind. normais em testes ergoespirométricos de caminhada de 6 min: hipóxia isocápnica(HPX),hipercapnia hiperóxica(HPC) e ar ambiente. HPX aumentou ventilação (VE) com resposta aguda(RVA), freq. cardíaca(FC) e volume de O2 consumido;reduziu o espaço morto,distância caminhada(DC) e pressão arterial sistêmica(PAS). A HPC aumentou VE acima da HPX com RVA.Os QP têm ação maior sobre FC e PAS do que QC, apesar da maior ativação simpática.QP possuem estimulo rápido sobre VE,porém menor do que QC. / Heart failure(HF) dyspnea is complex with potential enrolment of central(CC) and peripheric chemoreceptors(PC).We investigated CC and CP behavior through submaximal exercise in 15 HF patients and 7 normal subjects in treadmill 6-minute cardiopulmonary walking tests:isocapnic hypoxia(HPO), hypercapnia hyperoxic(HCP) and room air.HPO increased:ventilation(VE) with acute ventilatory response(AVR), heart rate (HR) and O2 uptake and reduced dead space, distance walked (DW) and systemic blood pressure(SBP).The HPC improved VE above HPO level with AVR. PC have greater action on HR and SBP than CC,despite their largest sympathetic activation. PC have faster impulse on VE although be lowest than CC
179

Etude de la biodistribution et de la toxicité des Nanoparticules de Fer chez le rat et sur une lignée de neuroblastome / Biodistribution and toxicity study of Iron Nanoparticles in rats and on a neuroblastoma cell line

Askri, Dalel 26 September 2018 (has links)
Les nanoparticules d'oxyde de fer sont utilisées dans plusieurs domaines notamment en Biomédecine comme agents théranostiques en Cancérologie et aussi comme agents de contraste en Imagerie par Résonance Magnétique. Avec l'augmentation de la production et de l'utilisation de ces NPs de fer, il y a une évidente augmentation de l'exposition humaine et environnementale à ces NPs, et qui peut présenter un risque. Le sujet de ma thèse porte sur l'étude de l’impact physiopathologique et de la toxicité des nanoparticules de fer (NPs de fer) en utilisant un modèle cellulaire de neuroblastome et un modèle d'étude animal, le rat Wistar. L’objectif des travaux de recherche de la partie in vitro est d’évaluer les effets cytotoxiques et génotoxiques ainsi que les effets sur l’expression des protéines cellulaires suite à l’exposition des cellules SH-SY5Y à des concentrations croissantes des NPs de fer. Nous avons montré que les NPs de fer induisent des perturbations cellulaires d’une manière dépendante de la taille et de la concentration. L'analyse protéomique suivie par l'annotation des gènes avec l’ontologie et l'analyse des voies de signalisation a mis en évidence les effets des NPs de fer sur le cytosquelette, l'apoptose et le développement du cancer. Les objectifs de nos travaux de recherche réalisés in vivo consistent à étudier les effets physiopathologiques des NPs de fer administrées par trois voies différentes, intraveineuse, intranasale et orale, à savoir leur impact sur le comportement émotionnel et cognitif ainsi que sur l’homéostasie des neurotransmetteurs et des éléments traces. Les résultats ont montré que les NPs de fer n’induisent pas de modification concernant l’anxiété, la locomotion, l’apprentissage et la mémoire chez le rat quelle que soit la voie d’administration. Cependant, ces NPs provoquent une perturbation des niveaux des catécholamines et des éléments traces au niveau cérébral. Les effets les plus marqués ont été observés suite à l’instillation intranasale des NPs et se manifestent par une diminution de taux du fer sérique, la thrombocytose et la présence des foyers inflammatoires au niveau hépatique. L’analyse comparative des trois voies d’administration a montré que la voie intraveineuse est la moins toxique. Enfin, l’étude protéomique des protéomes du cerveau, du foie et du poumon a permis d’évaluer la toxicité des NPs de fer au niveau protéique et moléculaire. Les résultats obtenus présentent un support important pour l’estimation et la compréhension des effets potentiellement adverses de ces NPs qui présentent une certaine toxicité non négligeable de point de vue moléculaire et physiopathologique. Ainsi, leur utilisation dans le domaine biomédicale doit être prise avec beaucoup de précaution pour éviter au maximum tout risque lié à leur exposition afin d’améliorer leur biocompatibilité et ainsi augmenter leurs avantages. / Iron Oxide Nanoparticles (IONPs) are used in several fields notably in Biomedicine as theranostic agents in Oncology and also as contrast agents in Magnetic Resonance Imaging. With the increase in the production and use of IONPs, there is a clear increase in human and environmental exposure to these NPs, which may pose a risk. The subject of my thesis is the study of the physiopathological impact and toxicity of iron oxide nanoparticles using a cell model of neuroblastoma and an animal study model, the Wistar rat. The aim of the research work of the in vitro part is to evaluate the cytotoxic and genotoxic effects as well as the effects on the expression of cellular proteins following the exposure of SH-SY5Y cells to increasing concentrations of iron NPs. We have shown that iron NPs induce cellular perturbations in a size and concentration dependent manner. Proteomic analysis followed by ontological gene annotation and signaling pathway analysis revealed the effects of IONPs on cytoskeleton, apoptosis and cancer development. The aims of our research carried out in vivo are to investigate the pathophysiological effects of iron NPs administered by three different routes, intravenous, intranasal and oral, also their impact on emotional and cognitive behavior as well as neurotransmitter and trace element homeostasis. The results showed that IONPs do not induce any changes in anxiety, locomotion, learning and memory in rats regardless of the administration route. However, these NPs cause a disruption of catecholamine and trace element levels in the brain. The most marked effects have been observed following intranasal instillation of NPs and are manifested by a decrease in serum iron levels, thrombocytosis and the presence of inflammatory foci in the liver. The comparative analysis of the three routes of administration showed that the intravenous route is the least toxic. Finally, the proteomic study of the proteomes of the brain, liver and lung has made it possible to evaluate the toxicity of the NPs of iron at the protein and molecular level. The obtained results provide an important support for the estimation and understanding of potentially adverse effects of these NPs, which have a certain toxicity that is not negligible from a molecular and physiopathological point of view. Thus, great care must be taken regarding their use in the biomedical field to minimize any risk related to IONP exposure in order to improve their biocompatibility and thus increase their benefits.
180

Malignant melanoma in Cape Town with the emphasis on this disease in black South Africans

Hudson, Donald Anthony 06 April 2017 (has links)
No description available.

Page generated in 0.051 seconds